1,246,744 Shares in Axon Enterprise, Inc $AXON Bought by Nykredit A S

Key Points

• Nykredit A S acquired 1.25 million Axon Enterprise shares during the second quarter, valued at approximately $699 million. The investment represents 2.2% of the fund’s portfolio and about 1.53% of Axon’s outstanding shares.
• Axon reported quarterly revenue of $904.4 million, up 35.3% year over year, and adjusted earnings of $1.88 per share, exceeding analyst expectations. Despite strong growth, the stock trades at a high valuation, with a price-to-earnings ratio of about 188.
• Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and an average price target of $721.57. However, recent insider selling and concerns about convertible-note dilution have weighed on investor sentiment.

Nykredit A S bought a new stake in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,246,744 shares of the biotechnology company's stock, valued at approximately $698,937,000. Axon Enterprise accounts for 2.2% of Nykredit A S's holdings, making the stock its 6th largest position. Nykredit A S owned approximately 1.53% of Axon Enterprise at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of AXON. Creative Financial Designs Inc. ADV acquired a new position in shares of Axon Enterprise in the 4th quarter valued at about $28,000. Keating Financial Advisory Services Inc. acquired a new stake in Axon Enterprise during the second quarter worth approximately $31,000. Washington Trust Advisors Inc. increased its holdings in Axon Enterprise by 1,300.0% in the second quarter. Washington Trust Advisors Inc. now owns 70 shares of the biotechnology company's stock worth $39,000 after purchasing an additional 65 shares in the last quarter. Delos Wealth Advisors LLC bought a new stake in Axon Enterprise in the second quarter worth approximately $45,000. Finally, Owl Creek Wealth Partners LLC boosted its holdings in shares of Axon Enterprise by 84.8% during the 2nd quarter. Owl Creek Wealth Partners LLC now owns 85 shares of the biotechnology company's stock worth $48,000 after buying an additional 39 shares in the last quarter. Institutional investors own 79.08% of the company's stock.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $453.50 on Friday. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47. The firm has a fifty day simple moving average of $549.86 and a two-hundred day simple moving average of $487.40. Axon Enterprise, Inc has a 12 month low of $339.01 and a 12 month high of $792.16. The firm has a market capitalization of $36.84 billion, a PE ratio of 188.18, a price-to-earnings-growth ratio of 8.82 and a beta of 1.40.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.84 by $0.04. The firm had revenue of $904.39 million during the quarter, compared to analysts' expectations of $876.42 million. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The business's revenue was up 35.3% on a year-over-year basis. During the same period last year, the company earned $2.12 earnings per share. Analysts forecast that Axon Enterprise, Inc will post 2.12 EPS for the current fiscal year.

Trending Headlines about Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon’s $1 billion financing carries a 0% coupon and gives the company substantial capital to invest in growth, products and acquisitions without immediate cash interest expense. Analysts remain broadly constructive, with the consensus rating described as “Moderate Buy.” Axon Announces Pricing of $1.0 Billion Offering of 0% Convertible Senior Notes Due 2031
• Positive Sentiment: A temporary advance in Axon stock occurred on above-average volume, with recent earnings-estimate revisions potentially supporting the company’s near-term outlook. Axon’s latest reported quarter also showed strong revenue growth, although valuation remains demanding. Strength Seen in Axon
• Neutral Sentiment: The convertible notes mature in 2031, and underwriters can purchase an additional $150 million. The long-dated, zero-coupon structure limits near-term interest costs, but the eventual conversion terms create uncertainty around future share issuance. What's Going On With Axon Shares on Wednesday?
• Negative Sentiment: Investors reacted negatively to the financing because convertible notes can dilute existing shareholders and raised questions about Axon’s cash-flow needs. Reports characterized the offering as the main catalyst for the selloff, causing the stock to underperform the broader market. Axon Enterprise Is Down After Convertible Notes Offering
• Negative Sentiment: Separate coverage cited insider selling and Axon’s elevated valuation as additional pressure points. With a high earnings multiple and a thin margin of safety, investors may be less tolerant of financing-related dilution or weaker cash-flow trends. Axon Shares Gap Down After Insider Selling

Insider Buying and Selling

In other Axon Enterprise news, insider Isaiah Fields sold 1,017 shares of Axon Enterprise stock in a transaction dated Friday, September 11th. The stock was sold at an average price of $480.45, for a total transaction of $488,617.65. Following the completion of the transaction, the insider owned 56,264 shares in the company, valued at approximately $27,032,038.80. The trade was a 1.78% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick Smith sold 10,000 shares of the business's stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $508.99, for a total value of $5,089,900.00. Following the sale, the chief executive officer directly owned 3,118,012 shares of the company's stock, valued at $1,587,036,927.88. This represents a 0.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 67,397 shares of company stock worth $38,160,884 over the last 90 days. Company insiders own 4.20% of the company's stock.

Analysts Set New Price Targets

Several analysts have recently commented on the stock. Morgan Stanley raised their price objective on shares of Axon Enterprise from $600.00 to $640.00 and gave the stock an "overweight" rating in a research report on Thursday, August 6th. Citizens Jmp reissued a "market outperform" rating and set a $700.00 target price on shares of Axon Enterprise in a research note on Thursday, June 25th. UBS Group lifted their price target on shares of Axon Enterprise from $440.00 to $600.00 and gave the company a "neutral" rating in a research note on Thursday, August 6th. Weiss Ratings reiterated a "hold (c-)" rating on shares of Axon Enterprise in a report on Wednesday, August 5th. Finally, Zacks Research cut shares of Axon Enterprise from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 10th. Fourteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $721.57.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and equipment for law enforcement, public safety and other government agencies. Its product portfolio includes TASER energy weapons, body-worn cameras, in-car cameras and related connected devices designed to support safer interactions, improve transparency and collect operational data.

The company also provides cloud-based software for managing digital evidence, conducting investigations, overseeing records and workflows, coordinating dispatch and supporting real-time public safety operations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.